Prospective Study on Anti-Helicobacter Pylori Therapy and Endoscopic Biopsy Following Surgery in Cases of Peptic Perforation
Authors/Creators
- 1. Associate Professor, Department of Pathology, M.K.C.G. Medical College, Berhampur, Odisha, India
- 2. Assistant Professor, Department of General Surgery, M.K.C.G. Medical College, Berhampur, Odisha, India
- 3. Professor, Department of General Surgery, M.K.C.G. Medical College, Berhampur, Odisha, India
- 4. Postgraduate, Department of General Surgery, M.K.C.G. Medical College, Berhampur, Odisha, India
Description
Background: The most common causes of peptic ulcer disease (PUD) are Helicobacter pylori infection and use of nonsteroidal anti-inflammatory drugs (NSAIDs), and the PUD leads to perforation. Perforation of gastric or duodenal ulcer is one of the most serious and overwhelming catastrophes that can befall on human being. The incidence of peptic ulcer disease has decline in worldwide in recent years following judicious use of wide spectrum and highly effective ulcer healing drugs. Despite the widespread use of gastric antisecretory agents and H. pylori eradication therapy the incidence of perforated peptic ulcer has changed little. Aim: The current study aims to check the involvement of the H. pylori in peptic perforations and whether by eradicating the bacterium H. pylori can we prevent the ulcer recurrence in post operative peptic perforation patients. Materials and Methods: After the confirmation of peptic perforation and detecting the H. pylori infection patients were subjected to graham’s repair by both open and laparoscopic method. Then after recovery they were included in the trial category. This study also involves the comparison between effectiveness of triple therapy regimen over esomeprazole alone therapy in post-operative periods. The patients were advised to follow up upto 1 year and ulcer recurrence was observed. Results: Study was conducted on 128 patients, out of which 68 were excluded and remaining 60 patients were included in the study. 30 patients were included in triple therapy group and 30 to only esomeprazole therapy group. After 1 yr. follow up it was found that 25(83.3%) out of 30 patients and 5(16.6%) out of 30 patients has H. pylori eradication. Ulcer recurrence occurred 3.3% in case triple therapy and 36.6% in case of only esomeprazole therapy. Conclusions: In this study it was found that in cases of peptic perforations triple therapy (anti- helicobacter pylori therapy) is superior to esomeprazole alone in the eradication of H. pylori. Triple therapy also prevents long term recurrence of ulcer in post operative peptic perforation in 1 year follow up study.
Abstract (English)
Background: The most common causes of peptic ulcer disease (PUD) are Helicobacter pylori infection and use of nonsteroidal anti-inflammatory drugs (NSAIDs), and the PUD leads to perforation. Perforation of gastric or duodenal ulcer is one of the most serious and overwhelming catastrophes that can befall on human being. The incidence of peptic ulcer disease has decline in worldwide in recent years following judicious use of wide spectrum and highly effective ulcer healing drugs. Despite the widespread use of gastric antisecretory agents and H. pylori eradication therapy the incidence of perforated peptic ulcer has changed little. Aim: The current study aims to check the involvement of the H. pylori in peptic perforations and whether by eradicating the bacterium H. pylori can we prevent the ulcer recurrence in post operative peptic perforation patients. Materials and Methods: After the confirmation of peptic perforation and detecting the H. pylori infection patients were subjected to graham’s repair by both open and laparoscopic method. Then after recovery they were included in the trial category. This study also involves the comparison between effectiveness of triple therapy regimen over esomeprazole alone therapy in post-operative periods. The patients were advised to follow up upto 1 year and ulcer recurrence was observed. Results: Study was conducted on 128 patients, out of which 68 were excluded and remaining 60 patients were included in the study. 30 patients were included in triple therapy group and 30 to only esomeprazole therapy group. After 1 yr. follow up it was found that 25(83.3%) out of 30 patients and 5(16.6%) out of 30 patients has H. pylori eradication. Ulcer recurrence occurred 3.3% in case triple therapy and 36.6% in case of only esomeprazole therapy. Conclusions: In this study it was found that in cases of peptic perforations triple therapy (anti- helicobacter pylori therapy) is superior to esomeprazole alone in the eradication of H. pylori. Triple therapy also prevents long term recurrence of ulcer in post operative peptic perforation in 1 year follow up study.
Files
IJPCR,Vol14,Issue6,Article91.pdf
Files
(290.6 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:3a1f806134db16893dae950179fa49b0
|
290.6 kB | Preview Download |
Additional details
Dates
- Accepted
-
2022-06-25
Software
- Repository URL
- https://impactfactor.org/PDF/IJPCR/14/IJPCR,Vol14,Issue6,Article91.pdf
- Development Status
- Active
References
- 1. Ng EKW, Lam YH, Sung JJY, Yung MY, To KF, Chan ACW, et al. Eradication of Helicobacter pylori Prevents Recurrence of Ulcer After Simple Closure of Duodenal Ulcer Perforation: Randomized Controlled Trial. Ann Surg. 2000 Feb;231(2):153– 8. 2. Moynihan Lord B.G.A 1926 Abd. Operations: 223 W B. Saunders Philadelphia. 3. Boey J. lee N. W. Womg J Surgery Gyn. And Obst. 155 193-196. 4. Henrey Med E. J. of Aust. J., Champan 1:50 - 53 B. L., Duggan J. M 1976. S.S. Yadav, Srinarayan. An experience withcases of peritonitis at Bheri Zonal Hospital, Nepalgunj. J Soc Surg Nepal 2002; 5(1): 33-36. 5. Delis S., Sotoropoulou. G., Argyriades. L & Derlopas K. 1997 B. J. S.Vol- 84 Suppl. 2, 141-142. 6. Dayal Yogeshwar et al: The gastrointestinal tract, Robbin's Pathologic Basis of Disease, 8th Edition, 2010; 763-832. 7. Chalapathy Rao P.V. et al: Experiences tic ulcer. Postgraduate medicine, 1962; 32: 119-126. With emergency vagotomy and draingae procedure for perforated duodenal ulcer, Indian Journal of Surgery. 1981; June: 419- 423. 8. Tsugawa K, Koyanagi N, Hashizume M, et al. Therapeutic strategies in performing emergency surgery for gastroduodenal perforation in 130 patients over 70 years of age. Hepatogastroenterology 2001; 48:156. 9. Drury JK, McKay AJ, Hutchison JS, Joffe SN. Natural history of perforated duodenal ulcers treated by suture closure. Lancet 1978; 2 (8093):749– 750. 10. Berthelot, M., Rieker, A., & Correia, J. C. The difficulties experienced bypatients with low back pain in France: a mixed methods study. Journal of Medical Research and Health Sciences, 2022:5(6), 2039–2048. 11. Sawyers JL, Herrington JL, Mulherin JO, Whitehead WA, Moby B, Marsh J. Acute perforated ulcer. An evaluation of surgical management. Arch Surg 1975; 110:527–530.